QYR Market Research Global Irritable Bowel Syndrome (IBS) market | Page 4

QYResearch
Currently, the IBS treatment market is naïve and
underpenetrated, with 4 products indicated for IBS in the
market. These include the IBS-C therapies, Amitiza
(lubiprostone, Sucampo/Takeda) and Linzess (linaclotide,
Ironwood/Allergan/Astellas); and the IBS-D therapies,
Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron,
Astellas). Antidepressants and antibiotics (mainly Xifaxan
[rifaximin], Valeant) are also used off-label to treat IBS.
PPT模板下载：www.1ppt.com/moban/
行业PPT模板：www.1ppt.com/hangye/
节日PPT模板：www.1ppt.com/jieri/
PPT素材下载：www.1ppt.com/sucai/
PPT背景图片：www.1ppt.com/beijing/
PPT图表下载：www.1ppt.com/tubiao/
优秀PPT下载：www.1ppt.com/xiazai/
PPT教程： www.1ppt.com/powerpoint/
Word教程： www.1ppt.com/word/
Excel教程：www.1ppt.com/excel/
资料下载：www.1ppt.com/ziliao/
PPT课件下载：www.1ppt.com/kejian/
范文下载：www.1ppt.com/fanwen/
试卷下载：www.1ppt.com/shiti/
教案下载：www.1ppt.com/jiaoan/
PPT论坛：www.1ppt.cn
www.qyresearch.com